Li Yang, Zhang Yang, Zhang Guifeng
National Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100190, China.
School of Chemical and Engineering, University of Chinese Academy of Sciences, Beijing 100049, China.
Curr Issues Mol Biol. 2024 Jul 19;46(7):7686-7701. doi: 10.3390/cimb46070455.
The importance of decellularized extracellular matrix (dECM) as a natural biomaterial in tissue engineering and regenerative medicine is rapidly growing. The core objective of the decellularization process is to eliminate cellular components while maximizing the preservation of the ECM's primary structure and components. Establishing a rapid, effective, and minimally destructive decellularization technique is essential for obtaining high-quality dECM to construct regenerative organs. This study focused on human umbilical cord tissue, designing different reagent combinations for decellularization protocols while maintaining a consistent processing time. The impact of these protocols on the decellularization efficiency of human umbilical cord tissue was evaluated. The results suggested that the composite decellularization strategy utilizing trypsin/EDTA + Triton X-100 + sodium deoxycholate was the optimal approach in this study for preparing decellularized human umbilical cord dECM. After 5 h of decellularization treatment, most cellular components were eliminated, confirmed through dsDNA quantitative detection, hematoxylin and eosin (HE) staining, and DAPI staining. Meanwhile, Masson staining, periodic acid-silver methenamine (PASM) staining, periodic acid-Schiff (PAS) staining, and immunofluorescent tissue section staining results revealed that the decellularized scaffold retained extracellular matrix components, including collagen and glycosaminoglycans (GAGs). Compared to native umbilical cord tissue, electron microscopy results demonstrated that the microstructure of the extracellular matrix was well preserved after decellularization. Furthermore, Fourier-transform infrared spectroscopy (FTIR) findings indicated that the decellularization process successfully retained the main functional group structures of extracellular matrix (ECM) components. The quantitative analysis of collagen, elastin, and GAG content validated the advantages of this decellularization process in preserving and purifying ECM components. Additionally, it was confirmed that this decellularized matrix exhibited no cytotoxicity in vitro. This study achieved short-term decellularization preparation for umbilical cord tissue through a combined decellularization strategy.
脱细胞细胞外基质(dECM)作为一种天然生物材料在组织工程和再生医学中的重要性正在迅速增长。脱细胞过程的核心目标是消除细胞成分,同时最大限度地保留细胞外基质的主要结构和成分。建立一种快速、有效且破坏性最小的脱细胞技术对于获得高质量的dECM以构建再生器官至关重要。本研究聚焦于人类脐带组织,在保持处理时间一致的同时,为脱细胞方案设计不同的试剂组合。评估了这些方案对人类脐带组织脱细胞效率的影响。结果表明,在本研究中,利用胰蛋白酶/乙二胺四乙酸(EDTA)+曲拉通X-100+脱氧胆酸钠的复合脱细胞策略是制备脱细胞人类脐带dECM的最佳方法。经过5小时的脱细胞处理后,通过双链DNA定量检测、苏木精和伊红(HE)染色以及4',6-二脒基-2-苯基吲哚(DAPI)染色证实,大部分细胞成分被消除。同时,Masson染色、高碘酸-银甲胺(PASM)染色、高碘酸-希夫(PAS)染色以及免疫荧光组织切片染色结果显示,脱细胞支架保留了包括胶原蛋白和糖胺聚糖(GAGs)在内的细胞外基质成分。与天然脐带组织相比,电子显微镜结果表明脱细胞后细胞外基质的微观结构得到了良好保存。此外,傅里叶变换红外光谱(FTIR)结果表明,脱细胞过程成功保留了细胞外基质(ECM)成分的主要官能团结构。胶原蛋白、弹性蛋白和GAG含量的定量分析验证了这种脱细胞过程在保存和纯化ECM成分方面的优势。此外,证实这种脱细胞基质在体外无细胞毒性。本研究通过联合脱细胞策略实现了脐带组织的短期脱细胞制备。